Home Amines 91271-79-3
91271-79-3,MFCD07329913
Catalog No.:AA00GTNT

91271-79-3 | 4-(PYRROLIDIN-1-YLMETHYL)BENZYLAMINE

Pack Size
Purity
Availability
Price(USD)
Quantity
  
50mg
95%
3 weeks  
$167.00   $117.00
- +
100mg
95%
3 weeks  
$190.00   $133.00
- +
250mg
95%
3 weeks  
$224.00   $157.00
- +
500mg
95%
3 weeks  
$308.00   $215.00
- +
1g
95%
3 weeks  
$417.00   $292.00
- +
2.5g
95%
3 weeks  
$708.00   $495.00
- +
5g
95%
3 weeks  
$995.00   $697.00
- +
10g
95%
3 weeks  
$1,424.00   $997.00
- +
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
Technical Information
Catalog Number:
AA00GTNT
Chemical Name:
4-(PYRROLIDIN-1-YLMETHYL)BENZYLAMINE
CAS Number:
91271-79-3
Molecular Formula:
C12H18N2
Molecular Weight:
190.2847
MDL Number:
MFCD07329913
SMILES:
NCc1ccc(cc1)CN1CCCC1
Properties
Computed Properties
 
Complexity:
156  
Covalently-Bonded Unit Count:
1  
Heavy Atom Count:
14  
Hydrogen Bond Acceptor Count:
2  
Hydrogen Bond Donor Count:
1  
Rotatable Bond Count:
3  
XLogP3:
1.1  

Downstream Synthesis Route

[1]Gemma,Sandra;Camodeca,Caterina;Brindisi,Margherita;Brogi,Simone;Kukreja,Gagan;Kunjir,Sanil;Gabellieri,Emanuele;Lucantoni,Leonardo;Habluetzel,Annette;Taramelli,Donatella;Basilico,Nicoletta;Gualdani,Roberta;Tadini-Buoninsegni,Francesco;Bartolommei,Gianluca;Moncelli,MariaRosa;Martin,RowenaE.;Summers,RobertL.;Lamponi,Stefania;Savini,Luisa;Fiorini,Isabella;Valoti,Massimo;Novellino,Ettore;Campiani,Giuseppe;Butini,Stefania[JournalofMedicinalChemistry,2012,vol.55,#23,p.10387-10404]

[2]CurrentPatentAssignee:INNOVSTONETHERAPEUTICS-WO2022/161420,2022,A1Locationinpatent:Page/Pagecolumn57

[3]CurrentPatentAssignee:ELILILLY&CO-WO2007/28083,2007,A2Locationinpatent:Page/Pagecolumn92-93

[4]CurrentPatentAssignee:ASTRAZENECAPLC-US6777561,2004,B1Locationinpatent:Pagecolumn34

91271-79-3   
4-4-(4-propylamino-6,7-dihydro-thieno3,2-dpyrimidin-2-yl)-piperazin-1-yl-N-(4-pyrrolidin-1-ylmethyl-benzyl)-benzamide 

[1]CurrentPatentAssignee:C.H.BoehringerSohnAG&Co.KG-US2007/259846,2007,A1Locationinpatent:Page/Pagecolumn33

[2]CurrentPatentAssignee:C.H.BoehringerSohnAG&Co.KG-WO2006/111549,2006,A1Locationinpatent:Page/Pagecolumn106;67

[1]CurrentPatentAssignee:GILEADSCIENCESINC-WO2011/31965,2011,A1Locationinpatent:Page/Pagecolumn72-73

[2]Roethle,PaulA.;McFadden,RyanM.;Yang,Hong;Hrvatin,Paul;Hui,Hon;Graupe,Michael;Gallagher,Brian;Chao,Jessica;Hesselgesser,Joseph;Duatschek,Paul;Zheng,Jim;Lu,Bing;Tumas,DanielB.;Perry,Jason;Halcomb,RandallL.[JournalofMedicinalChemistry,2013,vol.56,#18,p.7324-7333]

[1]Gemma,Sandra;Camodeca,Caterina;Brindisi,Margherita;Brogi,Simone;Kukreja,Gagan;Kunjir,Sanil;Gabellieri,Emanuele;Lucantoni,Leonardo;Habluetzel,Annette;Taramelli,Donatella;Basilico,Nicoletta;Gualdani,Roberta;Tadini-Buoninsegni,Francesco;Bartolommei,Gianluca;Moncelli,MariaRosa;Martin,RowenaE.;Summers,RobertL.;Lamponi,Stefania;Savini,Luisa;Fiorini,Isabella;Valoti,Massimo;Novellino,Ettore;Campiani,Giuseppe;Butini,Stefania[JournalofMedicinalChemistry,2012,vol.55,#23,p.10387-10404]

Literature

Title: Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.

Journal: Bioorganic & medicinal chemistry letters 20101101

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Tags:91271-79-3 Molecular Formula|91271-79-3 MDL|91271-79-3 SMILES|91271-79-3 4-(PYRROLIDIN-1-YLMETHYL)BENZYLAMINE